Articles On Micro-X (ASX:MX1)

Telehealth was already a growing space even before the pandemic, but COVID had launched it into the mainstream. At the height of the pandemic in 2020, data from Research and Markets showed that 76% of hospitals in the US were using teleheal...

Stockhead’s Top 10 at 10, published at 10.30am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers...

The ongoing lawsuit involving Johnson & Johnson (J&J)’s talc products took a controversial turn in the courts this week. The healthcare giant is currently staring down 38,000 claims that its talc products (including the famous baby...

Healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 24 years, explains what the movers and shakers have been doing in health and gives his ASX powerplays. Everyone loves a comeback. Just...

Healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 24 years, explains what the movers and shakers have been doing in health and gives his ASX powerplays. During his Australian Open quar...

At the time of writing, the ASX XHJ Healthcare index is up 5.55% over the last five trading days, beating the ASX200 benchmark index which was up 2.8% for the period. Here’s a table showing how ASX-listed healthcare stocks have been perform...

It’s been a rocky two weeks for small-cap health companies with 42 gaining ground, 76 losing it, and 21 flatlining.   Here’s a table showing how ASX-listed healthcare stocks have been performing. CODE COMPANY PRICE 1 WEEK RETURN %...

It’s been a rocky two weeks for small-cap health companies, with 27 companies gaining ground, 89 losing it and 21 flatlining.   Here’s a table showing how ASX-listed healthcare stocks have been performing. Code Name Price % Six Mont...

Healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 25 years, explains what the movers and shakers have been doing in health and gives his ASX powerplays.   Theme of the week At the time...

It’s been a rocky two weeks for small-cap health companies, with 33 companies gaining ground, 86 losing it and 16 flatlining.   Here’s a table showing how ASX-listed healthcare stocks have been performing. Code Company Price % Six M...

Healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 24 years, explains what the movers and shakers have been doing in health and gives his ASX powerplays.   Theme of the week The AGM sea...

Linius pursues commercialisation of video virtualisation engine tech UBI up after nabbing new distribution deal for its Sentia wine product Keypath unchanged 40.8% revenue increase to US$30.4 million   Linius Technologies (ASX:LNU) Cloud...

Healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 24 years, explains what the movers and shakers have been doing in health and gives his ASX powerplays.   Theme of the week At the time...

As well as covering large caps, many brokers also cover smaller companies. In light of this, I thought I would scour through a range of recent notes to see which small cap ASX shares are in favour with brokers at present. Three that have b...

Local stocks closed in the red on Wednesday (as expected), after US stocks posted their biggest fall since June overnight. The ASX 200 threatened to tank early but gained back some ground in afternoon trade to finish 1.08% lower. By sector,...

The ASX 200 closed 1% higher at 7,370 points, a level that saw it nearly recoup losses made earlier this week. The ASX Emerging Companies Index rose 1.64% to close at 2,554 points. All sectors were in the green with the biggest winners bein...

Leader of the ASX health stocks today is Imugene (ASX:IMU) up 4.11% after announcing plans to present its PD1-Vaxx cancer checkpoint immunotherapy program at the ESMO Congress 2021 Annual Meeting in Paris. The company says clinical results...

It was another day of gains for the ASX led by the energy sector. The ASX 200 rose by 0.116% to close at 7,437 while the ASX Emerging Companies Index rose 0.56% to close at 2,527. Although there was an even number of winners and losers amon...

ShareCafeHidden Gems Webinar Recap – Perpetual, OLL, FCT, LBT & MX1 Catch up on the full webinar with a keynote presentation from Perpetual & presentations from OpenLearning (ASX: OLL), First Wave Cloud Technology (ASX: FCT), LBT I...

ShareCafeMiniaturising X-Ray Peter Rowland – Managing Director – Micro-X Ltd is an award-winning ASX listed x-ray technology company. Miniaturising X-RayCompany News

Although earnings results were the main theme in August, there were also some notable healthcare breakthroughs on the ASX. Dimerix (ASX:DXB) jumped 45% during the month after announcing the commencement of ACTION 3, a Phase III study in pat...

Welcome to the FNArena Corporate Results Monitor. Today's Reports: ((AFG)) - Australian Finance Group ((BGA)) - Bega Cheese ((BEX)) - BikeExchange ((DTC)) - Damstra holdings ((DDH)) - DDH1 ((GDG)) - Generation Development ((GNX)) - Genex...

Highlights Low interest rate scenario is conducive for growth stocks. The technology sector has witnessed a major tail wind since the rapid digitisation post the COVID-19 outbreak. Knosys is to acquire a leading Library Management Sof...

It’s been a mixed two weeks for small-cap health companies, with only 45 companies gaining ground, 76 losing it and 23 flatlining. Rhinomed (ASX:RNO) was the biggest gainer, up a massive 85% for the fortnight after scoring a contract with N...

Trading Places is Stockhead’s recap of the buys and sells of ASX small cap shares by fund managers and other famous investors over the last fortnight. Specifically, Stockhead tracks substantial shareholder movements, being shareholders hold...

The ASX 200 health stocks index is tracking the broader index well over the past two weeks. Both the XHJ Health Sector and the ASX 200 benchmark rose by 3% over this period. A handful of ASX health stocks have seen their prices skyrocket du...

It’s been a mixed two weeks for small-cap health companies, with only 38 companies gaining ground, 74 losing it and 21 flatlining. Analytica Limited (ASX:ALT) was the biggest gainer, up 25% from 8 to 20 July, followed by  Rhinomed (ASX:RNO)...

It’s been a mixed two weeks for small-cap health companies, with 60 companies gaining ground and 52 losing it – and 21 flatlining. Botanix Pharma Ltd (ASX:BOT) was the biggest gainer, up 38% from 23 June to 7 July, and Suda Pharmaceuticals...

We’ve all heard the maxim that ‘time is money’, but in the case of stroke victims ‘time is brain’. From the moment of the dreaded incident, the clock is ticking on getting the patient to a suitably equipped hospital ASAP because millions of...

It wasn’t a happy start to the new financial year for Australia’s bourse, which lost nearly two thirds of one per cent today. Likewise, the ASX200, which rose 22% in FY21, closed down 0.65% to 7,266. Meanwhile, the ASX Emerging Companies In...

Healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 24 years, explains what the movers and shakers have been doing in health and gives his ASX powerplays.   Theme of the week Healthcare...

Here’s our fortnightly wrap of all the news driving ASX health stocks. The healthcare sector has returned 2.3 per cent for the last two weeks, compared to the broader market which rose by 2.7 per cent. The biggest news globally was out of U...

Healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 24 years, explains what the movers and shakers have been doing in health and gives his ASX powerplays.   Theme of the week It has been...

Peter Rowland, Managing Director of Micro-X (MX1) explains the significance of the next generation X-ray technology for global health and security markets.

The diagnostics imaging industry has come a long way since the days of X-rays and CT scans – two technologies that have been around for decades. Although they have not been replaced entirely, a breed of new ASX small caps have emerged over...

SeaTac chosen for Micro-X Inc’s USA headquartersOfficial Opening at 10 am PDT, Friday May 28855 S 192nd Street, Suite B600, Seattle, WA 98148 With: Congressman Adam Smith, chair of the House Armed Services Committee Brigadier Hugh Meggit...

Healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 24 years, explains what the movers and shakers have been doing in health and gives his ASX powerplays.   Themes of the week Healthcare...

Large and small caps had diverging fates on the ASX today with the former closing 0.32 per cent down from yesterday at 7,093 points while the ASX Emerging Companies Index rose 1.21 per cent to close at 2,159. The various ASX sectors were al...

Wall Street edges lower All major US indices fell overnight, as new US home sales slid by more than forecast. Dow Jones index was down by 0.24%, S&P500 by 0.21%, and tech heavy NASDAQ by 0.03%. The equity market dropped as the weak home...

The market looks caught in a fairly tight trading band since April as bulls and bears look to see who blinks first. In this climate, a good way to pick ASX shares to buy is to target those with positive near-term catalysts, according to Mo...

If you want to know which ASX stocks fund managers and famous investors are putting their money into we’ve been keeping track of substantial holder buys (and sells). Trading Places is Stockhead’s recap of the substantial holder movements am...

Healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 24 years, explains what the movers and shakers have been doing in health and gives his ASX powerplays.   Themes of the week Healthcare...

For all the leaps and bounds in medical science, the know-how behind detecting diseases hasn’t changed much in decades – or even centuries. Take X-rays, which are widely used despite the wee problem of irradiating the patients. And that’s b...

Healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 24 years, explains what the movers and shakers have been doing in health and gives his ASX powerplays. Themes of the week Healthcare f...

The capital raisings boom on the ASX is continuing in 2021 with nearly $10 billion raised in the first four months of the year. Across 325 deals, ASX companies have raised $9.878 billion in capital amidst IPOs, placements and rights issues....

ShareCafeHidden Gems Webinar Recap – PFG, EXL, MX1, BRU Catch up on the full webinar with a keynote presentation from Prime Financial Group (ASX: PFG), Elixinol Global (ASX: EXL), Micro-X (ASX: MX1) & Buru Energy (ASX: BRU) Hidden Gems...

ShareCafeMicro-X (ASX: MX1) – Hidden Gems Webinar Presentation Presenter – Peter Rowland – Managing Director – Micro–X Ltd is an award winning x-ray technology company. Micro–X Ltd is  a pioneer of a global revolution in medical and securi...

Healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 24 years, explains what the movers and shakers have been doing in health and gives his ASX powerplays.   Themes of the week The ASX he...

Healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 24 years, explains what the movers and shakers have been doing in health and gives his ASX powerplays.   Themes of the week After a re...

Here’s our fortnightly wrap of all the news driving ASX health stocks. It’s been a mixed two weeks for small-cap health companies, with 58 companies gaining ground and 54 losing it. Another 16 were flat. Code Company Price % return...